Eterna Therapeutics Inc. (ERNA)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 11.04M |
| Enterprise value | 53.38M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 95.97 |
| Price/book (mrq) | 1.40 |
| Enterprise value/revenue | 464.13 |
| Enterprise value/EBITDA | -0.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 8.01 |
| 52-week change 3 | -3.32% |
| S&P500 52-week change 3 | 24.52% |
| 52-week high 3 | 2.9900 |
| 52-week low 3 | 0.8400 |
| 50-day moving average 3 | 2.0532 |
| 200-day moving average 3 | 1.8449 |
Share statistics
| Avg vol (3-month) 3 | 8.29k |
| Avg vol (10-day) 3 | 5.95k |
| Shares outstanding 5 | 5.41M |
| Implied shares outstanding 6 | 5.41M |
| Float 8 | 2.95M |
| % held by insiders 1 | 39.31% |
| % held by institutions 1 | 7.56% |
| Shares short (15 May 2024) 4 | 52.84k |
| Short ratio (15 May 2024) 4 | 5.62 |
| Short % of float (15 May 2024) 4 | 1.28% |
| Short % of shares outstanding (15 May 2024) 4 | 0.98% |
| Shares short (prior month 15 Apr 2024) 4 | 40.08k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 17 Oct 2022 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -12,312.77% |
Management effectiveness
| Return on assets (ttm) | -40.81% |
| Return on equity (ttm) | -1,154.18% |
Income statement
| Revenue (ttm) | 115k |
| Revenue per share (ttm) | 0.02 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -21.04M |
| Net income avi to common (ttm) | -22.91M |
| Diluted EPS (ttm) | -4.2500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 5.12M |
| Total cash per share (mrq) | 0.95 |
| Total debt (mrq) | 47.45M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.79 |
| Book value per share (mrq) | -0.63 |
Cash flow statement
| Operating cash flow (ttm) | -18.11M |
| Levered free cash flow (ttm) | -11.3M |
© 2024 Yahoo. All rights reserved.